Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Fragile X Syndrome market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Fragile X Syndromemarket, defines the market attractiveness level of Fragile X Syndrome market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Fragile X Syndrome industry, describes the types of Fragile X Syndrome market, the applications of major players and the market size, and deeply analyzes the current situation of the global Fragile X Syndrome market and the development prospects and opportunities of Fragile X Syndrome industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Fragile X Syndrome market in Chapter 13.
By Player:
Bellus Health, Inc
Alcobra Ltd
Ovid Therapeutics Limited
Confluence Pharmaceuticals LLC
Anavex Life Sciences Corp
F Hoffmann-La Roche Ltd
Sage Therapeutics, Inc
MITO Technology SrL
AMO Pharma Limited
Neuren Pharmaceuticals Inc
Aelis Farma SAS
Marinus Pharmaceuticals, Inc
By Type:
ACT-01
AMO-01
ANAVEX-273
AUT-00206
Bryostatin-1
Cannabidiol
Others
By End-User:
Clinic
Hospital
Research Center
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Fragile X Syndrome Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Fragile X Syndrome Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Fragile X Syndrome Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Fragile X Syndrome Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Fragile X Syndrome Market Analysis and Outlook to 2022
-
7.1 Global Fragile X Syndrome Consumption (2017-2022)
-
7.2 United States Fragile X Syndrome Consumption (2017-2022)
-
7.3 Europe Fragile X Syndrome Consumption (2017-2022)
-
7.4 China Fragile X Syndrome Consumption (2017-2022)
-
7.5 Japan Fragile X Syndrome Consumption (2017-2022)
-
7.6 India Fragile X Syndrome Consumption (2017-2022)
-
7.7 South Korea Fragile X Syndrome Consumption (2017-2022)
8 Region and Country-wise Fragile X Syndrome Market Analysis and Outlook to 2028
-
8.1 Global Fragile X Syndrome Consumption Forecast (2022-2028)
-
8.2 United States Fragile X Syndrome Consumption Forecast (2022-2028)
-
8.3 Europe Fragile X Syndrome Consumption Forecast (2022-2028)
-
8.4 China Fragile X Syndrome Consumption Forecast (2022-2028)
-
8.5 Japan Fragile X Syndrome Consumption Forecast (2022-2028)
-
8.6 India Fragile X Syndrome Consumption Forecast (2022-2028)
-
8.7 South Korea Fragile X Syndrome Consumption Forecast (2022-2028)
9 Global Fragile X Syndrome Market Outlook by Types and Applications to 2022
-
9.1 Global Fragile X Syndrome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ACT-01 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AMO-01 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ANAVEX-273 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global AUT-00206 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Bryostatin-1 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Cannabidiol Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Fragile X Syndrome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)
10 Global Fragile X Syndrome Market Outlook by Types and Applications to 2028
-
10.1 Global Fragile X Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ACT-01 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AMO-01 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global ANAVEX-273 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global AUT-00206 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Bryostatin-1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Cannabidiol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Fragile X Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
11 Global Fragile X Syndrome Import and Export Analysis (Top 5 Countries)
-
11.1 Global Fragile X Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Fragile X Syndrome Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Fragile X Syndrome Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Fragile X Syndrome Market Competitive Analysis
-
14.1 Bellus Health, Inc
-
14.1.1 Bellus Health, Inc Company Details
-
14.1.2 Bellus Health, Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bellus Health, Inc Fragile X Syndrome Product and Service
-
14.2 Alcobra Ltd
-
14.2.1 Alcobra Ltd Company Details
-
14.2.2 Alcobra Ltd Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alcobra Ltd Fragile X Syndrome Product and Service
-
14.3 Ovid Therapeutics Limited
-
14.3.1 Ovid Therapeutics Limited Company Details
-
14.3.2 Ovid Therapeutics Limited Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Ovid Therapeutics Limited Fragile X Syndrome Product and Service
-
14.4 Confluence Pharmaceuticals LLC
-
14.4.1 Confluence Pharmaceuticals LLC Company Details
-
14.4.2 Confluence Pharmaceuticals LLC Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Confluence Pharmaceuticals LLC Fragile X Syndrome Product and Service
-
14.5 Anavex Life Sciences Corp
-
14.5.1 Anavex Life Sciences Corp Company Details
-
14.5.2 Anavex Life Sciences Corp Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Anavex Life Sciences Corp Fragile X Syndrome Product and Service
-
14.6 F Hoffmann-La Roche Ltd
-
14.6.1 F Hoffmann-La Roche Ltd Company Details
-
14.6.2 F Hoffmann-La Roche Ltd Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 F Hoffmann-La Roche Ltd Fragile X Syndrome Product and Service
-
14.7 Sage Therapeutics, Inc
-
14.7.1 Sage Therapeutics, Inc Company Details
-
14.7.2 Sage Therapeutics, Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sage Therapeutics, Inc Fragile X Syndrome Product and Service
-
14.8 MITO Technology SrL
-
14.8.1 MITO Technology SrL Company Details
-
14.8.2 MITO Technology SrL Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 MITO Technology SrL Fragile X Syndrome Product and Service
-
14.9 AMO Pharma Limited
-
14.9.1 AMO Pharma Limited Company Details
-
14.9.2 AMO Pharma Limited Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AMO Pharma Limited Fragile X Syndrome Product and Service
-
14.10 Neuren Pharmaceuticals Inc
-
14.10.1 Neuren Pharmaceuticals Inc Company Details
-
14.10.2 Neuren Pharmaceuticals Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Neuren Pharmaceuticals Inc Fragile X Syndrome Product and Service
-
14.11 Aelis Farma SAS
-
14.11.1 Aelis Farma SAS Company Details
-
14.11.2 Aelis Farma SAS Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Aelis Farma SAS Fragile X Syndrome Product and Service
-
14.12 Marinus Pharmaceuticals, Inc
-
14.12.1 Marinus Pharmaceuticals, Inc Company Details
-
14.12.2 Marinus Pharmaceuticals, Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Marinus Pharmaceuticals, Inc Fragile X Syndrome Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Fragile X Syndrome
-
Figure Fragile X Syndrome Picture
-
Table Global Fragile X Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fragile X Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fragile X Syndrome Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Fragile X Syndrome Consumption by Country (2017-2022)
-
Figure United States Fragile X Syndrome Consumption and Growth Rate (2017-2022)
-
Table Europe Fragile X Syndrome Consumption and Growth Rate (2017-2022)
-
Figure China Fragile X Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Japan Fragile X Syndrome Consumption and Growth Rate (2017-2022)
-
Figure India Fragile X Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Fragile X Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Fragile X Syndrome Consumption Forecast by Country (2022-2028)
-
Figure United States Fragile X Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Fragile X Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Fragile X Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Fragile X Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Fragile X Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Fragile X Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ACT-01 Consumption and Growth Rate (2017-2022)
-
Figure Global AMO-01 Consumption and Growth Rate (2017-2022)
-
Figure Global ANAVEX-273 Consumption and Growth Rate (2017-2022)
-
Figure Global AUT-00206 Consumption and Growth Rate (2017-2022)
-
Figure Global Bryostatin-1 Consumption and Growth Rate (2017-2022)
-
Figure Global Cannabidiol Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global ACT-01 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AMO-01 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ANAVEX-273 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AUT-00206 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bryostatin-1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cannabidiol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Fragile X Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Fragile X Syndrome Export by Region (Top 5 Countries) (2017-2028)
-
Table Bellus Health, Inc (Foundation Year, Company Profile and etc.)
-
Table Bellus Health, Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bellus Health, Inc Fragile X Syndrome Product and Service
-
Table Alcobra Ltd (Foundation Year, Company Profile and etc.)
-
Table Alcobra Ltd Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alcobra Ltd Fragile X Syndrome Product and Service
-
Table Ovid Therapeutics Limited (Foundation Year, Company Profile and etc.)
-
Table Ovid Therapeutics Limited Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ovid Therapeutics Limited Fragile X Syndrome Product and Service
-
Table Confluence Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)
-
Table Confluence Pharmaceuticals LLC Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Confluence Pharmaceuticals LLC Fragile X Syndrome Product and Service
-
Table Anavex Life Sciences Corp (Foundation Year, Company Profile and etc.)
-
Table Anavex Life Sciences Corp Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anavex Life Sciences Corp Fragile X Syndrome Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Fragile X Syndrome Product and Service
-
Table Sage Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Sage Therapeutics, Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sage Therapeutics, Inc Fragile X Syndrome Product and Service
-
Table MITO Technology SrL (Foundation Year, Company Profile and etc.)
-
Table MITO Technology SrL Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table MITO Technology SrL Fragile X Syndrome Product and Service
-
Table AMO Pharma Limited (Foundation Year, Company Profile and etc.)
-
Table AMO Pharma Limited Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMO Pharma Limited Fragile X Syndrome Product and Service
-
Table Neuren Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Neuren Pharmaceuticals Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neuren Pharmaceuticals Inc Fragile X Syndrome Product and Service
-
Table Aelis Farma SAS (Foundation Year, Company Profile and etc.)
-
Table Aelis Farma SAS Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aelis Farma SAS Fragile X Syndrome Product and Service
-
Table Marinus Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Marinus Pharmaceuticals, Inc Fragile X Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marinus Pharmaceuticals, Inc Fragile X Syndrome Product and Service
-
